Omega-3 fatty acids for depression in adults

  • Major change
  • Protocol
  • Intervention

Authors

  • Katherine M Appleton,

    Corresponding author
    1. Bournemouth University, Department of Psychology, Poole, UK
    • Katherine M Appleton, Department of Psychology, Bournemouth University, Poole House, Fern Barrow, Poole, BH12 5BB, UK. k.appleton@bournemouth.ac.uk.

    Search for more papers by this author
  • Rachel Perry,

    1. School of Oral and Dental Sciences, University of Bristol, The NIHR Biomedical Research Unit at the University of Bristol and the University Hospitals Bristol NHS Foundation Trust in Nutrition, Diet and Lifestyle, Bristol, UK
    Search for more papers by this author
  • Hannah M Sallis,

    1. University of Bristol, Centre for Academic Mental Health, School of Social and Community Medicine, Bristol, UK
    2. University of Bristol, MRC Integrative Epidemiology Unit, School of Social and Community Medicine, Bristol, UK
    Search for more papers by this author
  • Andrew R Ness,

    1. Level 3, University Hospitals Bristol Education Centre, NIHR Biomedical Research Unit in Nutrition, Diet and Lifestyle, Bristol, Avon, UK
    Search for more papers by this author
  • Rachel Churchill

    1. University of Bristol, Centre for Academic Mental Health, School of Social and Community Medicine, Bristol, UK
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of n3 polyunsaturated fatty acids (n3PUFAs) (also known as omega-3 fatty acids) compared with comparator (e.g. placebo, anti-depressant treatment, standard care, no treatment, wait-list control) for major depressive disorder in adults.